{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T17:28:05Z","timestamp":1785518885758,"version":"3.56.0"},"reference-count":96,"publisher":"Informa UK Limited","issue":"2","funder":[{"name":"Nikkiso"},{"name":"Mundipharma"},{"name":"Janssen"},{"DOI":"10.13039\/100006483","name":"Abbvie","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100006483","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Ferring"},{"name":"Takeda"},{"DOI":"10.13039\/100002429","name":"Amgen","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100002429","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Sandoz"},{"name":"Samsung Bioepis"},{"DOI":"10.13039\/100018592","name":"Celltrion","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100018592","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Alimentiv"},{"name":"Alma Bio Therapeutics"},{"DOI":"10.13039\/501100005105","name":"Arena","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100005105","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100005614","name":"Biogen","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100005614","id-type":"DOI","asserted-by":"crossref"}]},{"name":"CONNECT Biopharm"},{"name":"Cytoki Pharma"},{"name":"Enthera"},{"name":"Ferring"},{"DOI":"10.13039\/100017530","name":"Fresenius Kabi","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100017530","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100019832","name":"Galapagos","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100019832","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100008953","name":"Prometheus","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100008953","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100020154","name":"Protagonist","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100020154","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Theravance"},{"name":"Inotrem"},{"name":"Lilly"},{"DOI":"10.13039\/501100014841","name":"Medac","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100014841","id-type":"DOI","asserted-by":"crossref"}]},{"name":"HAC-Pharma"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Immunotherapy"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.2217\/imt-2023-0116","type":"journal-article","created":{"date-parts":[[2023,12,21]],"date-time":"2023-12-21T07:59:52Z","timestamp":1703145592000},"page":"59-74","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":15,"title":["The Role of Filgotinib in Ulcerative Colitis and Crohn\u2019s Disease"],"prefix":"10.1080","volume":"16","author":[{"given":"Jacopo","family":"Fanizza","sequence":"first","affiliation":[{"name":"Department of Gastroenterology & Endoscopy, IRCCS San Raffaele Hospital & Vita-Salute San Raffaele University, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ferdinando","family":"D\u2019Amico","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology & Endoscopy, IRCCS San Raffaele Hospital & Vita-Salute San Raffaele University, Milan, Italy"},{"name":"Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaetano","family":"Lauri","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology & Endoscopy, IRCCS San Raffaele Hospital & Vita-Salute San Raffaele University, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel J","family":"Martinez-Dominguez","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Hospital Cl\u00ednico Universitario Lozano Blesa, Zaragoza, Spain; Arag\u00f3n Health Research Institute, Zaragoza, Spain; School of Medicine, University of Zaragoza, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariangela","family":"Allocca","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology & Endoscopy, IRCCS San Raffaele Hospital & Vita-Salute San Raffaele University, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federica","family":"Furfaro","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology & Endoscopy, IRCCS San Raffaele Hospital & Vita-Salute San Raffaele University, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Zilli","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology & Endoscopy, IRCCS San Raffaele Hospital & Vita-Salute San Raffaele University, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gionata","family":"Fiorino","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology & Endoscopy, IRCCS San Raffaele Hospital & Vita-Salute San Raffaele University, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tommaso Lorenzo","family":"Parigi","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology & Endoscopy, IRCCS San Raffaele Hospital & Vita-Salute San Raffaele University, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simona","family":"Radice","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology & Endoscopy, IRCCS San Raffaele Hospital & Vita-Salute San Raffaele University, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"Peyrin-Biroulet","sequence":"additional","affiliation":[{"name":"University of Lorraine, Inserm, NGERE, F-54000 Nancy, France"},{"name":"Department of Gastroenterology, Nancy University Hospital, F-54500 Vand\u0153uvre-l\u00e8s-Nancy, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7341-1351","authenticated-orcid":false,"given":"Silvio","family":"Danese","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology & Endoscopy, IRCCS San Raffaele Hospital & Vita-Salute San Raffaele University, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2023,11,27]]},"reference":[{"key":"e_1_3_7_3_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra2002697"},{"key":"e_1_3_7_4_1","doi-asserted-by":"publisher","DOI":"10.1177\/17562848221142673"},{"key":"e_1_3_7_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2019.07.005"},{"key":"e_1_3_7_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2468-1253(19)30333-4"},{"key":"e_1_3_7_7_1","doi-asserted-by":"publisher","DOI":"10.1093\/ecco-jcc\/jjx107"},{"key":"e_1_3_7_8_1","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v22.i20.4794"},{"key":"e_1_3_7_9_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2021.10.035"},{"key":"e_1_3_7_10_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2020.12.036"},{"key":"e_1_3_7_11_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2020.12.031"},{"key":"e_1_3_7_12_1","doi-asserted-by":"publisher","DOI":"10.2174\/1389450115666140908125738"},{"key":"e_1_3_7_13_1","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v28.i47.6743"},{"key":"e_1_3_7_14_1","doi-asserted-by":"publisher","DOI":"10.1093\/ecco-jcc\/jjz180"},{"key":"e_1_3_7_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2020.01.017"},{"key":"e_1_3_7_16_1","doi-asserted-by":"publisher","DOI":"10.1093\/ibd\/izy238"},{"key":"e_1_3_7_17_1","doi-asserted-by":"publisher","DOI":"10.1093\/ecco-jcc\/jjy004"},{"key":"e_1_3_7_18_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11605-020-04832-y"},{"key":"e_1_3_7_19_1","doi-asserted-by":"publisher","DOI":"10.1111\/apt.13083"},{"key":"e_1_3_7_20_1","doi-asserted-by":"publisher","DOI":"10.1111\/apt.16785"},{"key":"e_1_3_7_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2468-1253(21)00377-0"},{"key":"e_1_3_7_22_1","doi-asserted-by":"publisher","DOI":"10.2147\/DDDT.S340459"},{"key":"e_1_3_7_23_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41572-020-0172-2"},{"key":"e_1_3_7_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2013.06.007"},{"key":"e_1_3_7_25_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.272.9.6073"},{"key":"e_1_3_7_26_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.271.10.5790"},{"key":"e_1_3_7_27_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41575-020-0273-0"},{"key":"e_1_3_7_28_1","doi-asserted-by":"publisher","DOI":"10.1080\/13543784.2018.1492547"},{"key":"e_1_3_7_29_1","doi-asserted-by":"publisher","DOI":"10.1080\/1744666X.2017.1291342"},{"key":"e_1_3_7_30_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-017-0701-9"},{"key":"e_1_3_7_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2012.03.013"},{"key":"e_1_3_7_32_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40262-016-0419-y"},{"key":"e_1_3_7_33_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10557-020-06943-9"},{"key":"e_1_3_7_34_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-06-164368"},{"key":"e_1_3_7_35_1","doi-asserted-by":"publisher","DOI":"10.1002\/eji.201646519"},{"key":"e_1_3_7_36_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-021-01214-y"},{"key":"e_1_3_7_37_1","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2019-318448"},{"key":"e_1_3_7_38_1","doi-asserted-by":"publisher","DOI":"10.1517\/13543784.2014.918604"},{"key":"e_1_3_7_39_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1606910"},{"key":"e_1_3_7_40_1","doi-asserted-by":"publisher","DOI":"10.1093\/ecco-jcc\/jjab206"},{"key":"e_1_3_7_41_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2019.04.059"},{"key":"e_1_3_7_42_1","doi-asserted-by":"publisher","DOI":"10.1111\/apt.15514"},{"key":"e_1_3_7_43_1","doi-asserted-by":"publisher","DOI":"10.1093\/ecco-jcc\/jjaa233"},{"key":"e_1_3_7_44_1","doi-asserted-by":"publisher","DOI":"10.1002\/prp2.537"},{"key":"e_1_3_7_45_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1201348"},{"key":"e_1_3_7_46_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2020-219012"},{"key":"e_1_3_7_47_1","unstructured":"European Medicines Agency . Jyseleca (2020). www.ema.europa.eu\/en\/medicines\/human\/EPAR\/jyseleca"},{"key":"e_1_3_7_48_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40262-022-01129-y"},{"key":"e_1_3_7_49_1","doi-asserted-by":"publisher","DOI":"10.1002\/cpdd.659"},{"key":"e_1_3_7_50_1","doi-asserted-by":"publisher","DOI":"10.1002\/cpdd.870"},{"key":"e_1_3_7_51_1","doi-asserted-by":"publisher","DOI":"10.2174\/1389200219666180821094502"},{"key":"e_1_3_7_52_1","doi-asserted-by":"publisher","DOI":"10.2174\/1872312810666151223103353"},{"key":"e_1_3_7_53_1","unstructured":"European Medicines Agency . Jyseleca: summary of product characteristics. www.ema.europa.eu\/en\/documents\/product-information\/jyseleca-epar-product-information_en.pdf"},{"key":"e_1_3_7_54_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40262-015-0240-z"},{"key":"e_1_3_7_55_1","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.13726"},{"key":"e_1_3_7_56_1","unstructured":"EMA Committee for Medicinal Products for Human Use . Assessment report: jyseleca (EMA\/424374\/2020). www.ema.europa.eu\/en\/documents\/assessment-report\/jyseleca-epar-public-assessment-report_en.pdf"},{"issue":"2","key":"e_1_3_7_57_1","first-page":"331","article-title":"Pharmacokinetics and short-term safety of filgotinib, a selective Janus kinase 1 inhibitor, in subjects with moderate hepatic impairment","volume":"78","author":"Anderson K","year":"2019","unstructured":"Anderson K , Zheng H , Medzihradsky O et al. Pharmacokinetics and short-term safety of filgotinib, a selective Janus kinase 1 inhibitor, in subjects with moderate hepatic impairment. Ann. Rheum. Dis. 78(2), 331 (2019).","journal-title":"Ann. Rheum. Dis."},{"key":"e_1_3_7_58_1","doi-asserted-by":"publisher","DOI":"10.1093\/ecco-jcc\/jjab232.076"},{"key":"e_1_3_7_59_1","doi-asserted-by":"publisher","DOI":"10.14309\/ajg.0000000000001979"},{"key":"e_1_3_7_60_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(21)00666-8"},{"key":"e_1_3_7_61_1","unstructured":"ClinicalTrials.gov . Filgotinib in long-term extension study of adults with ulcerative colitis. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02914535"},{"key":"e_1_3_7_62_1","doi-asserted-by":"publisher","DOI":"10.1080\/17474124.2022.2138857"},{"key":"e_1_3_7_63_1","doi-asserted-by":"publisher","DOI":"10.1093\/ecco-jcc\/jjab232.618"},{"issue":"1","key":"e_1_3_7_64_1","doi-asserted-by":"crossref","first-page":"i007","DOI":"10.1093\/ecco-jcc\/jjab232.006","article-title":"OP07 Exploring disease control by combining clinical, biological, and health-related quality of life remission with endoscopic improvements among ulcerative colitis patients treated with filgotinib: a post-hoc analysis from the SELECTION trial","volume":"16","author":"Schreiber S","year":"2022","unstructured":"Schreiber S , Feagan B , Peyrin-Biroulet L et al. OP07 Exploring disease control by combining clinical, biological, and health-related quality of life remission with endoscopic improvements among ulcerative colitis patients treated with filgotinib: a post-hoc analysis from the SELECTION trial. J. Crohns Colitis 16(1), i007\u2013i008 (2022).","journal-title":"J. Crohns Colitis"},{"key":"e_1_3_7_65_1","doi-asserted-by":"publisher","DOI":"10.2147\/CEG.S350193"},{"key":"e_1_3_7_66_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12325-022-02168-4"},{"key":"e_1_3_7_67_1","unstructured":"ClinicalTrials.gov . Study to evaluate the testicular safety of filgotinib in adult males with moderately to severely active inflammatory bowel disease (MANTA). https:\/\/clinicaltrials.gov\/ct2\/show\/record\/NCT03201445"},{"key":"e_1_3_7_68_1","unstructured":"ClinicalTrials.gov . Study to evaluate the effect of filgotinib on semen parameters in adult males with active rheumatoid arthritis psoriatic arthritis ankylosing spondylitis or non-radiographic axial spondyloarthritis (MANTA-RAy). https:\/\/classic.clinicaltrials.gov\/ct2\/show\/NCT03926195"},{"key":"e_1_3_7_69_1","unstructured":"Galapagos . Galapagos reports primary endpoint for the ongoing filgotinib manta and manta-ray safety studies (2021). www.glpg.com\/press-release\/2112\/galapagos-reports-primary-endpoint-for-the-ongoing-filgotinib-manta-and-manta-ray-safety-studies"},{"key":"e_1_3_7_70_1","doi-asserted-by":"publisher","DOI":"10.1080\/13543784.2022.2032639"},{"key":"e_1_3_7_71_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(16)32537-5"},{"key":"e_1_3_7_72_1","unstructured":"ClinicalTrials.gov . Efficacy and safety of filgotinib in the treatment of small bowel Crohn\u2019s disease (SBCD) (Divergence1). https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03046056?term=Divergence+1&draw=2&rank=1"},{"key":"e_1_3_7_73_1","unstructured":"ClinicalTrials.gov . Efficacy and safety of filgotinib in the treatment of perianal fistulizing Crohn\u2019s disease (Divergence2). https:\/\/clinicaltrials.gov\/ct2\/show\/record\/NCT03077412?term=Divergence+2&draw=2&rank=1"},{"key":"e_1_3_7_74_1","unstructured":"Galapagos . Galapagos announces topline results from phase 3 DIVERSITY trial of filgotinib in Crohn\u2019s disease (2023). www.glpg.com\/press-release\/3766\/galapagos-announces-topline-results-from-phase-3-diversity-trial-of-filgotinib-in-crohn-s-disease"},{"key":"e_1_3_7_75_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2020-218398"},{"key":"e_1_3_7_76_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard-2022-223715"},{"key":"e_1_3_7_77_1","doi-asserted-by":"publisher","DOI":"10.1080\/14656566.2023.2200931"},{"key":"e_1_3_7_78_1","unstructured":"European Medicines Agency . EMA recommends measures to minimise risk of serious side effects with Janus kinase inhibitors for chronic inflammatory disorders (2022). www.ema.europa.eu\/en\/news\/ema-recommends-measures-minimise-risk-serious-side-effects-janus-kinase-inhibitors-chronic"},{"key":"e_1_3_7_79_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2014.01.029"},{"key":"e_1_3_7_80_1","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2016-312735"},{"key":"e_1_3_7_81_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(22)00581-5"},{"key":"e_1_3_7_82_1","unstructured":"ClinicalTrials.gov . A study of the efficacy and safety of upadacitinib (ABT-494) in participants with moderately to severely active Crohn\u2019s disease who have inadequately responded to or are intolerant to biologic therapy. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03345836"},{"key":"e_1_3_7_83_1","unstructured":"ClinicalTrials.gov . A study of the efficacy and safety of upadacitinib in participants with moderately to severely active Crohn\u2019s disease who have inadequately responded to or are intolerant to conventional and\/or biologic therapies (U-EXCEL). https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03345849"},{"key":"e_1_3_7_84_1","unstructured":"ClinicalTrials.gov . A maintenance and long-term extension study of the efficacy and safety of upadacitinib (ABT-494) in participants with Crohn\u2019s disease who completed the studies M14\u2013431 or M14\u2013433. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03345823"},{"key":"e_1_3_7_85_1","unstructured":"European Medicines Agency . Rinvoq: Pending EC decision. www.ema.europa.eu\/en\/medicines\/human\/EPAR\/rinvoq"},{"key":"e_1_3_7_86_1","doi-asserted-by":"publisher","DOI":"10.1080\/17474124.2021.1898944"},{"key":"e_1_3_7_87_1","doi-asserted-by":"publisher","DOI":"10.1111\/apt.12507"},{"key":"e_1_3_7_88_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1602773"},{"key":"e_1_3_7_89_1","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10235660"},{"issue":"4","key":"e_1_3_7_90_1","first-page":"24","article-title":"Defining the difference: what makes biologics unique","volume":"1","author":"Morrow T","year":"2004","unstructured":"Morrow T , Felcone LH . Defining the difference: what makes biologics unique. Biotechnol. Healthc. 1(4), 24\u201329 (2004).","journal-title":"Biotechnol. Healthc."},{"key":"e_1_3_7_91_1","unstructured":"National Institute for Health and Care Excellence . Filgotinib for treating moderate to severe rheumatoid arthritis: guidance. www.nice.org.uk\/guidance\/ta676\/chapter\/2-Informationabout-filgotinib"},{"key":"e_1_3_7_92_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41575-022-00722-7"},{"key":"e_1_3_7_93_1","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2017.124"},{"key":"e_1_3_7_94_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2020.10.027"},{"key":"e_1_3_7_95_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2468-1253(21)00065-0"},{"key":"e_1_3_7_96_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2020.01.001"},{"key":"e_1_3_7_97_1","doi-asserted-by":"publisher","DOI":"10.1111\/jcpt.13622"},{"key":"e_1_3_7_98_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2021.03.034"}],"container-title":["Immunotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.2217\/imt-2023-0116","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,17]],"date-time":"2024-05-17T13:31:28Z","timestamp":1715952688000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.2217\/imt-2023-0116"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,27]]},"references-count":96,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,2]]}},"alternative-id":["10.2217\/imt-2023-0116"],"URL":"https:\/\/doi.org\/10.2217\/imt-2023-0116","relation":{},"ISSN":["1750-743X","1750-7448"],"issn-type":[{"value":"1750-743X","type":"print"},{"value":"1750-7448","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,27]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iimy20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iimy20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2023-06-04","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-10-09","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-11-27","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}